Hypoxia |
|
|
Clinical Trial: Home Stimulation for Brain-Asphyxiated Infants
This study is currently recruiting patients.
|
Purpose
This study examines the potential benefits of a home stimulation program to treat infants who have suffered from brain asphyxiation (lack of oxygen). The program involves one year of stimulatory activities. Progress will be evaluated through neurological and behavioral exams.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Hypoxia, Brain Hypoxia-Ischemia, Brain | Behavior: Infant stimulation | Phase II |
MedlinePlus related topics: Stroke
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study
Official Title: Neuroplasticity of Brain-Asphyxiated Infants: Efficacy of Intervention
Expected Total Enrollment: 120
Study start: September 1999; Expected completion: August 2004
Although the incidence of brain injury in infants is only 2 to 5 per 1000 births, the legal and medical costs, the developmental delays, and the impact on the family are profound. Twenty to 30% of survivors of brain injury have some long-term neurologic sequelae.
This randomized controlled trial will enroll 120 term and near-term neonates with a history of asphyxia to 1-year of a standard follow-up program (provided by the Los Angeles Regional Centers) or a home-based intervention program (Utah State University's Developmental Curriculum and Monitoring System, CAMS). The experimental intervention will include individualized cognitive/neuromotor stimulation given by the child's parents under the guidance of public health nurses. Following the intervention, measures will be used to determine functional capacity (Bayley II scale and neurologic examination), behavioral outcomes (HOME and NCAST by developmental specialists), and maternal outcomes (including parent-infant interaction and perceived stress). Infants will be assessed after the 1-year intervention by psychologists and physicians masked to the intervention. Functional MRI brain studies will be conducted at discharge and 18 months of age at UCLA to assess qualitative and quantitative sensorimotor representation. Secondary outcomes include care stress and social support as reported by parents, and demographics and medical factors obtained from the hospital records.
Eligibility
Ages Eligible for Study: up to 1 Month, Genders Eligible for Study: Both
Criteria
Inclusion Criteria
All of the following criteria must be met:
- Gestation age (GA) at birth >= 28 weeks
- Discharged to home care with parent or other guardian who has legal authority to give informed consent
- Greater than 10th percentile for GA at birth using the scales according to Lubchenco, Hansman, and Boyd from Pediatrics 1966 volume 37 and Battaglia and Lubchenco in the Journal of Pediatrics 1967 volume 71
- Jewelry in pierced body parts can be removed
- Mothers > 17 years old
- Recruited within 60 days of EDC (estimated date of conception)
Two or more of the following must be met:
- Intrapartum distress as determined by placental abruption, thick meconium staining of amniotic fluid, sustained fetal bradycardia of heart rate < 100 beats/min, or late or absent heart rate variability
- Profound metabolic or mixed academia as determined by umbilical artery pH < 7.0, base deficit of > 10 mEq/L or pH < 7.1 and base excess greater than 14 mmol/L within 72 hours of birth, Apgar score < 5 at 5 minutes or beyond, or need for positive pressure ventilation resuscitation for > 1 min after birth
- Neonatal neurological manifestations such as seizures during hospital stay, lethargy, hypotonia or hypertonia, stupor, flaccidity, or decerebration
- Multiple organ system dysfunction
- Abnormal EEG, CT scan, or MRI consistent with hypoxic or ischemic brain insult
Exclusion Criteria:
- Infants of substance abusing mothers (ISAM)
- Intrauterine growth retardation (IUGR)
- Infants requiring extracorporeal membrane oxygenation (ECMO) in the neonatal period
- Hearing or visual impairment
- Congenital cyanotic heart disease with cyanosis and requiring PGE infusion. Children with minimum cardiac structural anomalies (e.g., PDA or VSD or peripheral pulmonary stenosis) will not be excluded from the study.
- Congenital abnormalities of the central nervous system such as congenital hydrocephalus
- Grade IV intraventicular hemorrhage requiring ventriculo-peritoneal shunt (VP shunt)
- Trisomy 13, 18, or 21, or Fragile X
- Metabolic encephalopathy from inborn errors of metabolism (e.g. PKU, OTC)
- Metal or wire mesh implants, pacemaker implants, cochlear implants, orthopedic surgical wires or implants
- Status epilepticus
- Ventilator dependent at discharge
- Infectious meningitis
- Encephalitis with radiological evidence of severe cortical or severe hemispheric destruction
- Silastic catheters, broviacs, or Hickman port home TPA
- Infants who may not be available for the duration of the study
- Any infant who in the opinion of investigator has no potential to benefit from the intervention (e.g., children with prenatal herpes meningitis, severe cortical destruction, mother does not follow up with the intervention or with the follow-up appointments)
Location and Contact Information
California
University of California at Los Angeles, Los Angeles, California, 90095, United States; Recruiting
Meena Garg, MD, Principal Investigator, University of California at Los Angeles
More Information
Click here for more information on the National Institute of Child Health and Human Development clinical trials.
Record last reviewed: March 2003
Last Updated: October 13, 2004
Record first received: November 21, 2000
ClinicalTrials.gov Identifier: NCT00006516
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Anoxia (National Institute of Neurological Disorders and Stroke)
- Cerebral Hypoxia (Cleveland Clinic)

Not Signed In -

